Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:20:27 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Q:TBIO - TELESIS BIO INC - http://www.transgenomic.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TBIO - Q0.10.2753·0.37990.10.3184-0.013-3.926.25980.3174  0.3184  0.30783.01  0.2997Apr 26Apr 1815 min RT 2¢

Recent Trades - Last 10 of 98
Time ETExPriceChangeVolume
19:03:53Q0.32520.00383
18:56:44Q0.32550.004112
16:00:00Q0.3155-0.005928
15:58:50Q0.317-0.004459
15:58:50Q0.317-0.004459
15:58:02Q0.3184-0.00341
15:57:28Q0.3182-0.003227
15:57:18Q0.3181-0.0132899
15:57:18Q0.3183-0.013100
15:57:18Q0.3183-0.013100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 09:00U:TBIONews ReleaseTelesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
2024-03-28 16:05U:TBIONews ReleaseTelesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-26 09:15U:TBIONews ReleaseTelesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
2023-11-13 16:22U:TBIONews ReleaseTelesis Bio Reports Third Quarter 2023 Financial Results
2023-11-07 09:00U:TBIONews ReleaseTelesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
2023-11-03 12:00U:TBIONews ReleaseTelesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
2023-09-28 15:48U:TBIONews ReleaseTelesis Bio Announces Commercial Release of BioXp ‚ ® NGS Library Prep Kit for WGS
2023-08-29 16:05U:TBIONews ReleaseTelesis Bio Appoints William J. Kullback Chief Financial Officer
2023-08-10 16:05U:TBIONews ReleaseTelesis Bio Reports Second Quarter 2023 Financial Results
2023-08-03 17:00U:TBIONews ReleaseTelesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
2023-06-08 09:05U:TBIONews ReleaseTelesis Bio to Present at Jefferies Healthcare Conference 2023
2023-06-06 03:00U:TBIONews ReleaseTelesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
2023-06-05 17:30U:TBIONews ReleaseTelesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
2023-05-31 17:29U:TBIONews ReleaseTelesis Bio Secures Financing of $28.0 Million
2023-05-23 09:00U:TBIONews ReleaseTelesis Bio to Present at SynBioBeta 2023
2023-05-22 12:00U:TBIONews ReleaseTelesis Bio Announces First Commercial Shipment of BioXp ‚ ® Select DNA Cloning Kit
2023-05-18 10:00U:TBIONews ReleaseTelesis Bio Announces First Commercial Shipment of BioXp ‚ ® NGS Library Prep Kit
2023-05-15 09:00U:TBIONews ReleaseTelesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
2023-05-11 16:05U:TBIONews ReleaseTelesis Bio Reports First Quarter 2023 Financial Results